We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Vivacelle Bio

News List

Vivacelle Bio Receives Award from Navy for VBI-S Trial for Hypovolemia of Septic Shock Due to COVID americanpharmaceuticalreview
December 10, 2020
Vivacelle Bio announces the Department of Defense awarded $5.3 million dollars for the clinical trial of VBI-S, an intravenously injected fluid based upon Vivacelle Bio's phospholipid nanoparticle technology for the treatment of septic shock due to ...
Vivacelle Bio Receives FDA Clearance to Enroll Patients into its Phase IIa Trial of VBI-1 americanpharmaceuticalreview
February 18, 2019
Vivacelle Bio announced the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and ....